CPG
DMAC icon

Cornerstone Planning Group’s DiaMedica Therapeutics DMAC Stock Holding History

Cornerstone Planning Group’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$555 Hold
80
– – ﹤0.01% 1665
2026
Q1 		$500 Hold
80
– – ﹤0.01% 1648
2025
Q4 		$675 Buy
80
+74
+1,233% +$553 ﹤0.01% 1443
2025
Q3 		$758 Sell
6
-74
-93% -$401 ﹤0.01% 1378
2025
Q2 		$359 Hold
80
– – ﹤0.01% 1388
2025
Q1 		$317 Hold
80
– – ﹤0.01% 1397
2024
Q4 		$485 Hold
80
– – ﹤0.01% 1151
2024
Q3 		$346 Buy
+80
New +$295 ﹤0.01% 1165

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Cornerstone Planning Group's DMAC Position: Q2 2026 in Review

Cornerstone Planning Group held its DiaMedica Therapeutics (DMAC) position steady in Q2 2026 at 80 shares worth $555. The position accounts for ﹤0.01% of the portfolio, ranked #1665.

Cornerstone Planning Group first reported a position in DMAC in Q3 2024 and has held it in 8 quarters since. The position peaked at $758 in Q3 2025. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Cornerstone Planning Group held 80 shares of DiaMedica Therapeutics worth $555 as of Q2 2026.
  • Cornerstone Planning Group left its DiaMedica Therapeutics share count unchanged in Q2 2026.
  • DiaMedica Therapeutics made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #1665 holding.
  • Cornerstone Planning Group first reported a position in DiaMedica Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Cornerstone Planning Group's DiaMedica Therapeutics position peaked at $758 in Q3 2025.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.